Press Releases

LEXINGTON, Mass. , March 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences , (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced that a
Read More
LEXINGTON, Mass. , March 04, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced the
Read More
LEXINGTON, Mass. , Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced the
Read More
Displaying 11 - 14 of 14
Print Page
Email Alerts
RSS
Investor Contact
Search